Watson Pharmaceuticals, Inc. ( WPI ) recently announced that it gained US Food and Drug Administration (FDA) approval for its generic version of Ferring Pharmaceuticals’ Lysteda
Radiosurgery systems maker, Accuray Incorporated ( ARAY ) announced preliminary results for the second quarter of fiscal 2013 as well as provided guidance for fiscal 2013. The company